Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Molecular Neurodegeneration|November 17, 2023
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementiaTetiana Poliakova, Cheryl L WellingtonCurrent Opinion in Lipidology|May 6, 2016
Relation between plasma and brain lipidsCheryl L Wellington, Ruth Frikke-SchmidtCurrent Opinion in Lipidology|May 15, 2007
Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's diseaseVeronica Hirsch-Reinshagen, Cheryl L WellingtonCell Metabolism|February 11, 2014
High-density lipoproteins and cerebrovascular integrity in Alzheimer's diseaseSophie Stukas, Jérôme Robert, Cheryl L WellingtonCardiovascular Research|June 9, 2014
HDL and cholesterol handling in the brainCecilia Vitali, Cheryl L Wellington, Laura CalabresiMolecular and Cellular Biochemistry|January 1, 2009
Why lipids are important for Alzheimer disease?Veronica Hirsch-Reinshagen, Braydon L Burgess, Cheryl L WellingtonNeuron|August 9, 2019
Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced NeurodegenerationDanielle K Sandsmark, Asma Bashir, Cheryl L Wellington, et al.Current Gerontology and Geriatrics Research|June 1, 2012
Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levelsGavin Tansley, Daniel T Holmes, Dieter Lütjohann, et al.Clinical Chemistry and Laboratory Medicine|October 26, 2023
Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohortSophie Stukas, Jennifer Cooper, Victoria Higgins, et al.Biochimica Et Biophysica Acta|September 6, 2011
The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1Sophie Stukas, Sharon May, Anna Wilkinson, et al.Pageof 12